Skip to main content

Advertisement

Log in

Clinical remission of IgA nephropathy in an HIV-positive patient after combined treatment with tonsillectomy and steroid pulse therapy

  • Case Report
  • Published:
CEN Case Reports Aims and scope Submit manuscript

Abstract

Various renal diseases other than human immunodeficiency virus (HIV)-associated nephropathy, including IgA nephropathy (IgAN), have been recently reported to cause chronic kidney disease and end-stage renal disease in HIV-infected patients. The case of a 37-year-old HIV-infected male diagnosed as having IgAN with proteinuria and microscopic hematuria that was successfully treated with tonsillectomy and steroid pulse therapy in combination, resulting in disappearance of urinary abnormalities (clinical remission), is reported, the first such case in the literature. A renal biopsy revealed mesangial proliferation associated with mesangial deposition of IgA and C3, consistent with IgAN. Antiretroviral therapy and angiotensin receptor blocker therapy did not improve his proteinuria. Therefore, he underwent tonsillectomy and steroid pulse therapy, and clinical remission was successfully achieved with no opportunistic infections. Clinical remission has continued for more than 3 years even after discontinuation of steroid therapy. It appears that combined treatment with tonsillectomy and steroid pulse therapy can be a good choice in managing HIV-infected patients with IgAN as long as secondary infection is strictly and continuously monitored.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Barratt J, Feehally J. Treatment of IgA nephropathy. Kidney Int. 2006;69:1934–8.

    Article  CAS  PubMed  Google Scholar 

  2. Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, Abe K, Taguma Y. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis. 2001;38:736–43.

    Article  CAS  PubMed  Google Scholar 

  3. Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Kitamura K. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol. 2008;3:1301–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Elewa U, Sandri AM, Rizza SA, Fervenza FC. Treatment of HIV-associated nephropathies. Nephron Clin Pract. 2011;118:c346–54.

    Article  CAS  PubMed  Google Scholar 

  5. Klotman PE. HIV-associated nephropathy. Kidney Int. 1999;56:1161–76.

    Article  CAS  PubMed  Google Scholar 

  6. Kimura T, Yasuda K, Obi Y, Satoh T, Namba T, Sasaki K, Muramoto N, Wada A, Rakugi H, Isaka Y, Hayashi T. A case of HIV-associated nephropathy accompanied by nephrotic syndrome and acute worsening of kidney function. (In Japanese). Jpn J Nephrol. 2012;54:94–8.

    Google Scholar 

  7. Sasaki E, Shibata M, Kato A, Hamano N, Katsuki T, Katsuma A, Tada M, Hinoshita F. A case of serious HIV-associated nephropathy resulting in the introduction of hemodialysis. (In Japanese). Jpn J Nephrol. 2013;55:1335–9.

    Google Scholar 

  8. Nebuloni M, Barbiano di Belgiojoso G, Genderini A, Tosoni A, Riani LN, Heidempergher M, Zerbi P, Vago L. Glomerular lesions in HIV-positive patients: a 20-year biopsy experience from northern Italy. Clin Nephrol. 2009;72:38–45.

    Article  CAS  PubMed  Google Scholar 

  9. Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM, Ronco P, Pialoux G, Plaisier E. HIV-associated kidney glomerular diseases: changes with time and HAART. Nephrol Dial Transplant. 2012;27:2349–55.

    Article  PubMed  Google Scholar 

  10. Szczech LA, Gupta SK, Habashi R, Guash A, Kalayjian R, Appel R, Fields TA, Svetkey LP, Flanagan KH, Klotman PE, Winston JA. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004;66:1145–52.

    Article  PubMed  Google Scholar 

  11. Weiner NJ, Goodman JW, Kimmel PL. The HIV-associated renal diseases: current insight into pathogenesis and treatment. Kidney Int. 2003;63:1618–31.

    Article  PubMed  Google Scholar 

  12. Katz A, Bargman JM, Miller DC, Guo JW, Ghali VS, Schoeneman MJ. IgA nephritis in HIV-positive patients: a new HIV-associated nephropathy? Clin Nephrol. 1992;38:61–8.

    CAS  PubMed  Google Scholar 

  13. Gorriz JL, Rovira E, Sancho A, Ferrer R, Paricio A, Pallardo LM. IgA nephropathy associated with human immuno deficiency virus infection: antiproteinuric effect of captopril. Nephrol Dial Transpl. 1997;12:2796–7.

    Article  CAS  Google Scholar 

  14. Hsieh WS, Szukala S, Howell DN, Conlon PJ. Crescentic IgA nephropathy and acute renal failure in an HIV-positive patient with enteric salmonella infection. Nephrol Dial Transpl. 1996;11:2320–3.

    Article  CAS  Google Scholar 

  15. Beaufils H, Jouanneau C, Katlama C, Sazdovitch V, Hauw JJ. HIV-associated IgA nephropathy–a post-mortem study. Nephrol Dial Transpl. 1995;10:35–8.

    Article  CAS  Google Scholar 

  16. Jindal KK, Trillo A, Bishop G, Hirsch D, Cohen A. Crescentic IgA nephropathy as a manifestation of human immune deficiency virus infection. Am J Nephrol. 1991;11:147–50.

    Article  CAS  PubMed  Google Scholar 

  17. Cohen SD, Kimmel PL. Immune complex renal disease and human immunodeficiency virus infection. Semin Nephrol. 2008;28:535–44.

    Article  PubMed  Google Scholar 

  18. Imai H, Miura N. A treatment dilemma in adult immunoglobulin A nephropathy: what is the appropriate target, preservation of kidney function or induction of clinical remission? Clin Exp Nephrol. 2012;16:195–201.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Herman ES, Klotman PE. HIV-associated nephropathy: epidemiology, pathogenesis, and treatment. Semin Nephrol. 2003;23:200–8.

    Article  PubMed  Google Scholar 

  20. Eustace JA, Nuermberger E, Choi M, Scheel PJ Jr, Moore R, Briggs WA. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int. 2000;58:1253–60.

    Article  CAS  PubMed  Google Scholar 

  21. Smith MC, Austen JL, Carey JT, Emancipator SN, Herbener T, Gripshover B, Mbanefo C, Phinney M, Rahman M, Salata RA, Weigel K, Kalayjian RC. Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am J Med. 1996;101:41–8.

    Article  CAS  PubMed  Google Scholar 

  22. Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV medicine association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40:1559–85.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors have declared that no conflict of interest exists.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Manami Tada.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tada, M., Masumoto, S. & Hinoshita, F. Clinical remission of IgA nephropathy in an HIV-positive patient after combined treatment with tonsillectomy and steroid pulse therapy. CEN Case Rep 4, 157–161 (2015). https://doi.org/10.1007/s13730-014-0158-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13730-014-0158-6

Keywords

Navigation